Mechanistically, the LCAT1/IGF2BP2 complex stabilized CDC6 mRNA via the m6A modification to increase the translation of CDC6, which then promoted the growth and survival of lung cancer cells. This evidence concerns the gene IGF2BP2 and lung carcinoma.